Etravirine 200 mg formulation available in UK

1 February 2012. Related: Antiretrovirals.

On 17 January 2012, Janssen announced the launch of a 200 mg formulation of the NNRTI etravirine (Intelence).

The recommended oral dose of 200 mg etravirine is one tablet taken twice daily following a meal. The previous formulation required 2 x 100 mg twice-daily.

These tablets are dispersible in a glass of water. This option may be important given the new pill is slightly larger than the 100 mg formulation (22 mm vs 19 mm long).

The monthly list price for the 200 mg formulation is matched to the current daily price for the 100 mg formulation at £301.27.

Source: Janssen PR: Janssen launches 200mg etravirine (Intelence) for anti-retroviral treatment-experienced adults with HIV-1. (17 January 2012).